Search Results for: space

Weekly reads: stem cell therapy for vision loss, cancer self-experimentation, Slovenia, 14-day rule

limbal stem cell deficiency LSCD, stem cell therapy for vision loss

Is there a proven stem cell therapy for vision loss? When I started The Niche back in early 2010, one major area of hope was that there might one day be a stem cell therapy for vision loss or even blindness. Maybe even a cure for blindness. While we’re not there yet as a field, […]

Weekly reads: stem cell therapy for vision loss, cancer self-experimentation, Slovenia, 14-day rule Read More »

Poll on stem cell & regenerative medicine good news of 2024

stem cell good news, good news

What are the most significant stem cell and regenerative medicine good news stories of 2024? Since it has been an eventful year, there are many possibilities. Please see our poll at the bottom of this post and weigh in on what you think is the most important encouraging news. If you don’t see your choice

Poll on stem cell & regenerative medicine good news of 2024 Read More »

Weekly reads: patient views on stem cell clinics, vertebrate super-pygmies, Tasmanian tiger, low back pain

stem cell clinics map

What do patients who go to stem cell clinics really think of their experiences? It can be hard to get good data on this important question. For that reason, it was great to see a new article on this topic. With perhaps around 2,000 unproven clinics in the U.S., these firms are likely to have

Weekly reads: patient views on stem cell clinics, vertebrate super-pygmies, Tasmanian tiger, low back pain Read More »

FDA’s CBER fires off 3 more warning letters on cellular biologics for a total of 12 in 2024

Something seems to have dramatically changed with the FDA at its Center for Biologics Evaluation and Research or CBER. Did they start handing out free Red Bull by the case? So many recent FDA warnings on cell and tissue biologics CBER is the part of the FDA that regulates regenerative medicine products like stem cells,

FDA’s CBER fires off 3 more warning letters on cellular biologics for a total of 12 in 2024 Read More »

Given their legal conflict, will Cryo-Cell & Duke still turn to donor units for kids with CP?

Duke Cryo-Cell therapeutic misconception

The Parent’s Guide to Cord Blood Foundation recently announced that Cryo-Cell and its long-time partner, a Duke pediatric cell therapy team, have made a key change. They will begin offering infusions of unrelated, unproven cord blood to pediatric patients with cerebral palsy (CP). These are called donor infusions. Up until now, they had mainly focused

Given their legal conflict, will Cryo-Cell & Duke still turn to donor units for kids with CP? Read More »

Weekly reads: stem cell patches, helicase editing, hearing loss, Astellas, Dr. No

New research on stem cell patches is exciting. However, more broadly, “stem cell patches” can mean very different things. What I’m talking about here are the types of patches that can repair holes or other problems with tissues. This is a powerful regenerative approach. In contrast, I’m not a fan of the type of stem cell

Weekly reads: stem cell patches, helicase editing, hearing loss, Astellas, Dr. No Read More »

Cryo-Cell alleges Duke acted “fraudulently” related to pediatric cord cell deal

Cryo Cell, Cryo-Cell

Cord blood banker Cryo-Cell and Duke have had a long-running agreement. The potentially multi-million dollar deal has focused on the development of possible umbilical cord blood therapies for pediatric patients. A major first goal has been to open an infusion clinic, which I have been very skeptical about for various reasons. For instance, one big

Cryo-Cell alleges Duke acted “fraudulently” related to pediatric cord cell deal Read More »

Liveyon made $21.6 million says DOJ; leader gets 3 years prison for stem cell activities

Liveyon

Back in late August, Liveyon leader John Kosolcharoen pleaded to federal charges on stem cells. What was Liveyon? Liveyon was a splashy umbilical cord stem cell supplier company. I don’t know if the company is still active now. One of its core products ended up sending dozens of people to the hospital due to contamination

Liveyon made $21.6 million says DOJ; leader gets 3 years prison for stem cell activities Read More »

ISCT launches new resource on unproven cell & gene therapies

ISCT, ISCT guide

The International Society for Cell & Gene Therapy or ISCT is a great organization in our field. They have launched a new guide to help healthcare providers navigate this complex area. Click on the image below to check it out. This new resource is important because healthcare providers, researchers, and the public need authoritative information.

ISCT launches new resource on unproven cell & gene therapies Read More »